|
DNAJA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.87149987016267E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.71489514097811E-11 |
| Normal-vs-Stage2 |
1.434320E-04 |
| Normal-vs-Stage3 |
2.207800E-02 |
| Normal-vs-Stage4 |
3.796000E-03 |
| Stage1-vs-Stage2 |
9.078400E-01 |
| Stage1-vs-Stage3 |
2.632100E-02 |
| Stage1-vs-Stage4 |
3.729800E-01 |
| Stage2-vs-Stage3 |
1.266440E-01 |
| Stage2-vs-Stage4 |
4.488600E-01 |
| Stage3-vs-Stage4 |
6.051800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.78729961123281E-10 |
| Normal-vs-AfricanAmerican |
3.27670002242542E-09 |
| Normal-vs-Asian |
7.980800E-01 |
| Caucasian-vs-AfricanAmerican |
6.100200E-01 |
| Caucasian-vs-Asian |
9.043600E-02 |
| AfricanAmerican-vs-Asian |
2.514200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39550038191771E-10 |
| Normal-vs-Female |
2.17759999998623E-06 |
| Male-vs-Female |
1.308440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.15089995498397E-09 |
| Normal-vs-Extreme_Weight |
1.05169983832809E-10 |
| Normal-vs-Obese |
1.90543999999404E-05 |
| Normal-vs-Extreme_Obese |
5.18440000041309E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.419600E-01 |
| Normal_Weight-vs-Obese |
2.982200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.099600E-01 |
| Extreme_Weight-vs-Obese |
2.779600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.761600E-01 |
| Obese-vs-Extreme_Obese |
1.980160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.021180E-01 |
| Normal-vs-Age(41-60Yrs) |
1.95729999985517E-08 |
| Normal-vs-Age(61-80Yrs) |
2.46500042599962E-10 |
| Normal-vs-Age(81-100Yrs) |
3.0529999994755E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.892400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.404800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.004400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.888220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.564170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.059800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.73999711808415E-11 |
| Normal-VS-Type2 PRCC |
2.29089999999044E-05 |
| Normal-VS-KIRP CIMP |
9.001000E-01 |
| Normal-VS-Unclassified PRCC |
3.53080000004002E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.606000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.221540E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.275000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.304100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.369000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.958100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.18280000016568E-07 |
| Normal-vs-N1 |
6.302100E-02 |
| Normal-vs-N2 |
6.40499999999822E-05 |
| N0-vs-N1 |
2.845600E-02 |
| N0-vs-N2 |
3.718800E-01 |
| N1-vs-N2 |
6.412000E-02 |
|
|
